Comprehensive Library Of Resveratrol News

Yes, what is obvious has been confirmed.  Despite unfounded claims that all of the research studies showing resveratrol protects heart muscle tissue during a heart attack, even Wikipedia spreads misinformation that that fact is in question due to bogus allegations of scientific fraud against a leading resveratrol scientist.  Canadian researchers unequivocally show that resveratrol protects the heart under conditions of biological stress induced by instillation of hydrogen peroxide by maintaining antioxidant enzymes (catalase, superoxide dismutase).  Once damaged (scarred), heart muscle cells (cardiomyocytes) are not rapidly repaired.  So it is critical to protect these cells.  Resveratrol does something that no existing cardiac drug an do — protect the heart prior to a heart attack (this is called cardioprotection).  It has been called the most ideal form of heart protection.  Based upon animal lab studies, cardioprotection has been demonstrated to have the potential to turn otherwise mortal heart attacks into non-mortal events, which is more than aspirin or statin drugs can do.  — Bill Sardi, ResveratrolNews.com

Read the whole post »

• Would it abolish the first sign of arterial aging in humans?
• Would it spare adults from losing their eyesight as they progressively age?
• Would it turn mortal heart attacks into non-mortal events?
• Would it inhibit the growth of blood vessels that feed solid tumors and prevent them from growing?
• Would it be non-toxic at almost any dose tested?

The fact is, such a pill already exists.

Click on the underlined links above to learn more.

–Bill Sardi, ResveratrolNews.com

From: The Association for Research in Vision & Ophthalmology (ARVO) annual meeting, Fort Lauderdale, Fla.,

Ft. Lauderdale, FL (May 6, 2012) – There may be new found hope for patients whose vision is threatened when medicine injected directly into the eyes fails to cause abnormal blood vessels to recede. While injectable drugs called angiogenesis (an-gee-oh-jen-esis) inhibitors are considered a modern miracle and have become the standard of care for patients with the fast-progressive form of macular degeneration, they are not foolproof. For the first time researchers report that an oral nutriceutical, used on a last-resort clinical basis, rapidly restores vision to otherwise hopeless patients who face permanent loss.

Stuart Richer OD, PhD, Director, Ocular Preventative Medicine-Eye Clinic, James A. Lovell Federal Health Care Center, North Chicago, Illinois, says all other therapies were exhausted before employing the oral nutriceutical under compassionate-use protocols on a case-by-case basis. Usually most patients respond to medicine injected directly into the eyes, he says, but only about one in three patients recover driving vision and one in six patients go on to experience permanent vision loss and others may refuse needle injections directly into the eyes, making them candidates for this rescue medicine.

Three successfully treated cases were presented at the annual Association for Research in Vision & Ophthalmology meeting in Ft. Lauderdale, Florida.

Read the whole post »

http://www.nrcresearchpress.com/doi/pdf/10.1139/y2012-065

Dr. Thomas Netticadan
Canadian Centre for Agri-food Research
in Health and Medicine,
Winnipeg, Manitoba

Thank you for your comments published at Canadian Journal Physiology & Pharmacology regarding resveratrol research.  ( http://www.nrcresearchpress.com/doi/pdf/10.1139/y2012-065 )

Let it be said that:

1. University of Connecticut withdrew its online allegations against Dr. Das once confronted with inconsistencies in their 49-page summary about the alleged scientific fraud.

Read the whole post »